Wegovy, Zepbound, Saxenda, and other GLP-1 or GIP medications are needlessly out of reach for many Americans.

The health care industry is at a breaking point. Patients — health plan customers — feel unheard, undervalued, and exploited, ...

Clinical trials—and all the other studies that inform the health care each of us receives—have long had issues with most of ...

A caucus in the Pennsylvania House focused on maternal health has introduced bills that would protect the right to public ...

UF Health North opened in 2015 as a medical office building. Two years later, it expanded to include the only full-service ...

Montgomery County, Pennsylvania, officials say a baby who has been diagnosed with measles visited two health care facilities ...

The study ranked Minnesota as the best state for health care, while Mississippi ranked last. New York placed 38th in the ...

Dialysis firm Fresenius Medical Care shares fell 7.8% after German healthcare group Fresenius SE sold part of its stake in ...

Before ProPublica’s reporting on the deaths of Amber Thurman and Candi Miller, the names of committee members had been ...

Plaintiffs accused Sutter Health, a nonprofit, of illegally wielding its market power to drive up Californians' health care ...

Despite operating losses, Excellus Healthcare pointed to stronger-than-expected investment returns for helping the insurer ...

The AHEAD Model, a federal program to reform how Vermont pays for health care, faces an uncertain future. In July 2024, the secretary of Vermont’s Agency of Human Services announced that the state had ...